Perfusion of antifungal agents through biofilms of Candida sp.

Current Science

Volumn 94, Issue 6, 2008, Pages 774-777

  Subha, T S ^a   Gnanamani, A ^a  

^a CENTRAL LEATHER RESEARCH INSTITUTE   (India)

Author keywords

Antifungal agents; Biofilms; Drug resistance; Perfusion

Indexed keywords

CANDIDA; CANDIDA ALBICANS; CANDIDA TROPICALIS;

EID: 42149175497     PISSN: 00113891     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Baillie, G. S. and Douglas, L. J., Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents. Antimicrob. Agents Chemother., 1998, 42, 1900-1905.
2. Donlan, R. M. and Costerton, J. W., Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev., 2002, 15, 167-193.
3. Douglas, L. J., Medical importance of biofilms in Candida infections. Rev. Iberoam. Micol., 2002, 19, 139-143.
4. Douglas, L. J., Candida biofilms and their role in infection. Trends Microbiol., 2003, 11, 30-36.
5. Kumamoto, C. A., Candida biofilms. Curr. Opin. Microbiol., 2002, 5, 608-611.
6. Alem, M. A. S. and Douglas, L. J., Effects of Aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans. Antimicrob. Agents Chemother., 2004, 48, 41-47.
7. Crump, J. A. and Collingnon, P. J., Intravascular catheter-associated infections. Eur. J. Clin. Microbiol. Infect. Dis., 2000, 19, 1-8.
8. Ramage, G., Walle, K. V., Wickes, B. L. and Lopez-Ribot, J. L., Biofilm formation by Candida dubliniensis. J. Clin. Microbiol., 2001, 39, 3234-3240.
9. Trick, W. E. and Jarvis. W. R., Epidemiology of nosocomial fungal infection in the 1990s. Rev. Iberoam. Micol., 1998, 15, 2-6.
10. Ernst, E. J., Yodoi, K., Roling, E. E. and Klepser, M. E., Rates and extends of antifungal activities of Amphothericin B, Flucytosine, Luconazole, and Voriconazoles against Candida lusitaniae determined by microdilution, etest and determined by time-kill methods. J. Antimicrob. Agents Chemother., 2001, 46, 578-581.
11. Baillie, G. S. and Douglas, L. J., Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J. Antimicrob. Chemother., 2000, 46, 397-403.
12. Hawser, S. P. and Douglas, L. J., Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob. Agents Chemother., 1995, 39, 2128-2131.
13. Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., Cormick, T. Mc. and Ghannoum, M. A., Biofilm formation by the fungal pathogen Candida albicans: Development, architecture, and drug resistance. J. Bacteriol., 2001, 183, 5385-5394.
14. Cocuaud, C., Rodier, M. H., Daniault, G. and Imbert, C., Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms. J. Antimicrob. Chemother., 2005, 56, 507-512.
15. Al-Fattani, M. A. and Douglas, L. J., Penetration of Candida biofilms by antifungal agents. Antimicrob. Agents Chemother., 2004, 48, 3291-3297.
16. Samaranayake, Y. H., Ye, J., Yau, J. Y. Y., Cheung, B. P. K. and Samaranayake, L. P., In vitro method to study antifungal perfusion in Candida biofilms. J. Clin. Mircobiol., 2004, 43, 818-825.
17. Kuhn, D. M., Chandra, J., Mukherjee, P. K. and Ghannoum, M. A., Comparison of biofilm formation Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect. Immunol., 2000, 70, 878-888.
18. Kojie, E. M. and Darouchie, R. O., Candida infections of medical devices. Clin. Microbiol. Rev., 2004, 17, 255-267.
19. Mukherjee, P. K. and Chandra, J., Candida biofilm resistance. Drug Resistance Updates, 2004, 7, 301-309.
20. Ramage, G., Walle, K. V., Wickes, B. L. and Lopez-Ribot, J. L., Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. J. Antimicrob. Agents Chemother., 2001, 45, 2475-2479.
21. Baillie, G. S. and Douglas, L. J., Iron limited biofilms of Candida albicans and their susceptibility to Amphothericin B. Antimicrob. Agents Chemother., 1998, 42, 2146-2149.
22. García-Sánchez, S., Aubert, S., Iraqui, S., Janbon, G., Ghigo, J. and d'Enfert, C., Candida albicans biofilms: A developmental state associated with specific and stable gene expression patterns. Eukaryot. Cell., 2004, 3, 536-545.
23. Hawser, S. P., Jessup, C., Vitullo, J. and Ghannoum, M. A., Utility of 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[phenyl-amino) carbonyl-2H-tetrazolium hydroxide (XTT) and minimum effective concentration assays in the determination of antifungal susceptibility of Aspergillus fumigatus to the lipopeptide class of compounds. J. Clin. Microbiol., 2001, 39, 2738-2741.
24. Ramage, G., Bachmann, S., Patterson, T. F., Wickes, B. L. and Lopez-Ribot, J. L., Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J. Antimicrob. Chemother., 2002, 49, 973-980.
25. Gilfillan, G. D. Sullivan, D. J., Haynes, K., Parkinson, T., Coleman, D. C. and Gow, N. A. R., Candida dubliniensis: Phylogeny and putative virulence factors. Microbiology, 1998, 144, 829-838.
26. McCourtie, J. and Douglas, L. J., Relationship between cell surface composition, adherence, and virulence of Candida albicans. Infect. Immunol., 1984, 45, 6-12.
27. Odds, F. C., Gow, N. A. R. and Brown, A. J. P., Fungal virulence studies come of age. Genome Biol., 2004, 2, 1009.1-1009.4.
28. Ramage, G. Saville, S. P., Thomas, D. P. and Lopez-Ribot, J. L., Candida biofilms: An update. Eukaryot. Cell, 2005 4, 633-638.